Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Overweight and obese individuals are encouraged to lose 5–10% of their body weight to improve cardiovascular disease (CVD) risk, but data supporting this recommendation are limited, particularly for individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS: We conducted an observational analysis of participants in the Look AHEAD (Action For Health in Diabetes) study (n = 5,145, 40.5% male, 37% from ethnic/racial minorities) and examined the association between the magnitude of weight loss and changes in CVD risk factors at 1 year and the odds of meeting predefined criteria for clinically significant improvements in risk factors in individuals with type 2 diabetes. RESULTS: The magnitude of weight loss at 1 year was strongly (P < 0.0001) associated with improvements in glycemia, blood pressure, tryiglycerides, and HDL cholesterol but not with LDL cholesterol (P = 0.79). Compared with weight-stable participants, those who lost 5 to <10% ([means ± SD] 7.25 ± 2.1 kg) of their body weight had increased odds of achieving a 0.5% point reduction in HbA1c (odds ratio 3.52 [95% CI 2.81–4.40]), a 5-mmHg decrease in diastolic blood pressure (1.48 [1.20–1.82]), a 5-mmHg decrease in systolic blood pressure (1.56 [1.27–1.91]), a 5 mg/dL increase in HDL cholesterol (1.69 [1.37–2.07]), and a 40 mg/dL decrease in triglycerides (2.20 [1.71–2.83]). The odds of clinically significant improvements in most risk factors were even greater in those who lost 10–15% of their body weight. CONCLUSIONS: Modest weight losses of 5 to <10% were associated with significant improvements in CVD risk factors at 1 year, but larger weight losses had greater benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“behavioral weight loss (BWL) is the gold-standard non-surgical treatment for weight loss”
From Associations Between Self-Monitoring and Weight Change in Behavioral Weight Loss Interventions (2019) · cites this paper as Wing et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight loss across a spectrum of elevated BMIs produces not only improvements in glucose levels and the traditional cardiovascular intermediate risk factors 28 but also reductions in ectopic adipose tissue depots that may contribute to atherosclerosis and myocardial dysfunction. 29”
From Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These reductions are associated in a generally linear manner with improvements in cardiovascular disease (CVD) risk factors, quality of life, and prevention of type 2 diabetes [24–26].”
From The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities (2023) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For people living with obesity, losing 5% to 10% of body weight can lead to a substantial reduction in risk factors for diabetes, cardiovascular disease, and stroke [8].”
From Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It should be noted, however, that the clinical benefits of weight loss are progressive, and more intensive weight loss goals (i.e., 15%) may be appropriate to maximize benefit depending on need, feasibility, and safety (106,107).”
From 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023 (2023) · cites this paper as [107]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
(1998) · PubMed · Cited by 2,737
Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522
Beneficial health effects of modest weight loss.
Dj, G. (1992) · PubMed · Cited by 1,263
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162
Self-citationThe Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It
The Look AHEAD Research Group (2006) · Obesity · doi:10.1038/oby.2006.84 · Cited by 873
The Look AHEAD Research Group (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00064-3 · Cited by 767
Cited by
Items 301–400 of 1,007
Ectopic fat deposition and global cardiometabolic risk: New paradigm in cardiovascular medicine
Shimabukuro, M., Kozuka, C., Taira, S.-I., Yabiku, K., Dagvasumberel, M., Ishida, M., Matsumoto, S., Yagi, S., Fukuda, D., Yamakawa, K., et al. (2013) · The Journal of Medical Investigation · doi:10.2152/jmi.60.1 · Cited by 66
Fujishima, Y., Maeda, N., Inoue, K., Kashine, S., Nishizawa, H., Hirata, A., Kozawa, J., Yasuda, T., Okita, K., Imagawa, A., et al. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-107 · Cited by 65
Alamuddin, N., Bakizada, Z. M., & Wadden, T. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.8806 · Cited by 74
Self-citationFlodgren, G., Gonçalves, D. C., & Summerbell, C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000984.pub3 · Cited by 84
Peptide‐based multi‐agonists: a new paradigm in metabolic pharmacology
Brandt, S. J., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Stemmer, K. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12837 · Cited by 65
Naslund, J. A., Aschbrenner, K. A., Marsch, L. A., McHugo, G. J., & Bartels, S. J. (2018) · Psychiatric Quarterly · doi:10.1007/s11126-017-9512-0 · Cited by 64
Associations Between Self-Monitoring and Weight Change in Behavioral Weight Loss Interventions
Goldstein, S. P., Goldstein, C. M., Bond, D. S., Raynor, H. A., Wing, R. R., & Thomas, J. G. (2019) · Health Psychology · doi:10.1037/hea0000800 · Cited by 63
“…M anuscript Keywords weight loss; self-monitoring; mobile health; adherence Background Obesity remains a major public health concern and behavioral weight loss (BWL) is the gold-standard non-surgical treatment for weight loss (Hales, Fryar, Carroll, Freedman, & Ogden, 2018; Wing et al., 2011).”
BackgroundSelf-citationPoddar, K. H., Ames, M. L., Hsin-Jen, C., Feeney, M. J., Wang, Y., & Cheskin, L. J. (2013) · Appetite · doi:10.1016/j.appet.2013.09.008 · Cited by 74
Premium-Based Financial Incentives Did Not Promote Workplace Weight Loss In A 2013–15 Study
Patel, M. S., Asch, D. A., Troxel, A. B., Fletcher, M., Osman-Koss, R., Brady, J. L., Wesby, L., Hilbert, V., Zhu, J., Wang, W., et al. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.0945 · Cited by 71
Kotinda, A. P. S. T., de Moura, D. T. H., Ribeiro, I. B., Singh, S., Neto, A. M. D. P., Proença, Í. M., Flor, M. M., de Souza, K. L., Bernardo, W. M., & de Moura, E. G. H. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04558-5 · Cited by 73
Barnason, S. A., Zimmerman, L. M., Schulz, P., Pullen, C. H., & Schuelke, S. A. (2019) · Journal of Clinical Nursing · doi:10.1111/jocn.14784 · Cited by 71
CEASER, T. G., & Hunter, G. R. (2015) · Sports Medicine · doi:10.1007/s40279-015-0318-7 · Cited by 64
Look AHEAD Research Group, Wing, R. R., Bray, G. A., Cassidy-Begay, M., Clark, J. M., Coday, M., Egan, C., Evans, M., Foreyt, J. P., Glasser, S., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1805 · Cited by 61
Self-citationLong-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
Mirabelli, M., Chiefari, E., Caroleo, P., Arcidiacono, B., Corigliano, D. M., Giuliano, S., Brunetti, F. S., Tanyolaç, S., Foti, D. P., Puccio, L., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17010207 · Cited by 61
Sharples, A. J., Charalampakis, V., Daskalakis, M., Tahrani, A. A., & Singhal, R. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2677-7 · Cited by 67
Di Prospero, N. A., Yee, J., Frustaci, M. E., Samtani, M. N., Alba, M., & Fleck, P. (2021) · Clinical Obesity · doi:10.1111/cob.12433 · Cited by 60
“individuals with obesity can be drastically reduced through weight loss, a measure that has also been shown to significantly improve metabolic parameters and cardiovascular risk factors in obese people with established T2DM.(6-11) Current treatment options for reducing body weight in people with obesity are limited an…”
BackgroundNamazi, N., Mahdavi, R., Alizadeh, M., & Farajnia, S. (2015) · Phytotherapy Research · doi:10.1002/ptr.5417 · Cited by 60
Aschbrenner, K. A., Naslund, J. A., Shevenell, M., Kinney, E., & Bartels, S. J. (2016) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000530 · Cited by 60
Soltanian, N., & Janghorbani, M. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0273-z · Cited by 59
Behavioral Treatment of the Patient with Obesity
Alamuddin, N., & Wadden, T. A. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.04.008 · Cited by 65
Self-citationNatural disaster and immunological aging in a nonhuman primate
Watowich, M. M., Chiou, K. L., Montague, M. J., Simons, N. D., Horvath, J. E., Ruiz-Lambides, A. V., Martínez, M. I., Higham, J. P., Brent, L. J. N., Platt, M. L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121663119 · Cited by 59
Impact of avocado-enriched diets on plasma lipoproteins: A meta-analysis
Peou, S., Millard-Hasting, B. M., & Shah, S. A. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.10.011 · Cited by 70
The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes (Revised)
(2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872287 · Cited by 69
The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
Crane, J., & McGowan, B. (2016) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315620180 · Cited by 59
The new era of drug therapy for obesity: the evidence and the expectations
Jones, B. J., & Bloom, S. R. (2015) · Drugs · doi:10.1007/s40265-015-0410-1 · Cited by 58
Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s365416 · Cited by 58
“Approximately 46(6)–68%(7) of participants achieve a ≥5% initial weight loss, which is associated with clinically significant health benefits.(4,8,9) However, translation and implementation of ILI into clinical and community settings has been challenging due to time, knowledge, and resource limitations.”
BackgroundSelf-citationWilson, R., Deasy, W. J., Stathis, C. G., Hayes, A., & Cooke, M. B. (2018) · Nutrients · doi:10.3390/nu10030346 · Cited by 79
Alfaris, N., Wadden, T. A., Sarwer, D. B., Diwald, L., Volger, S., Hong, P., Baxely, A., Minnick, A. M., Vetter, M. L., Berkowitz, R. I., et al. (2015) · Obesity · doi:10.1002/oby.20996 · Cited by 57
“Losses of this magnitude are considered clinically meaningful because of their reduction of traditional CVD risk factors, including triglyceride levels, blood pressure, and blood glucose.1,2 The present study found that a loss ≥5% also was associated with improvements in two behavioral risk factors for CVD – short sle…”
BackgroundMethodInfluentialSelf-citationGastric Sensory and Motor Functions and Energy Intake in Health and Obesity—Therapeutic Implications
Cifuentes, L., Camilleri, M., & Acosta, A. (2021) · Nutrients · doi:10.3390/nu13041158 · Cited by 57
Defries, D. M., Taylor, C. G., Appah, P., Blewett, H., & Zahradka, P. C. (2013) · Metabolism · doi:10.1016/j.metabol.2013.01.021 · Cited by 62
Swencionis, C., Wylie-Rosett, J., Lent, M. R., Ginsberg, M., Cimino, C., Wassertheil-Smoller, S., Caban, A., & Segal-Isaacson, C.-J. (2013) · Health Psychology · doi:10.1037/a0029186 · Cited by 57
Toohey, K. L., Pumpa, K. L., Arnolda, L., Cooke, J., Yip, D., Craft, P., & Semple, S. (2016) · PeerJ · doi:10.7717/peerj.2613 · Cited by 59
Lew, K. S., Pearson, J. T., Schwenke, D. O., & Katare, R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0484-4 · Cited by 60
Pharmacotherapy for Obesity—Trends Using a Population Level National Database
Elangovan, A., Shah, R., & Smith, Z. L. (2021) · Obesity Surgery · doi:10.1007/s11695-020-04987-2 · Cited by 56
Jiskoot, G., Timman, R., Beerthuizen, A., Dietz de Loos, A., Busschbach, J., & Laven, J. (2020) · Obesity · doi:10.1002/oby.22980 · Cited by 56
Strelitz, J., Ahern, A. L., Long, G. H., Hare, M. J. L., Irving, G., Boothby, C. E., Wareham, N. J., & Griffin, S. J. (2019) · Diabetologia · doi:10.1007/s00125-019-4886-1 · Cited by 56
Edible Mushrooms as Novel Myco-Therapeutics: Effects on Lipid Level, Obesity and BMI
Mustafa, F., Chopra, H., Baig, A. A., Avula, S. K., Kumari, S., Mohanta, T. K., Saravanan, M., Mishra, A. K., Sharma, N., & Mohanta, Y. K. (2022) · Journal of Fungi · doi:10.3390/jof8020211 · Cited by 63
Mathieu, C., Barnett, A. H., Brath, H., Conget, I., Castro, J. J., Göke, R., Rodriguez, E. M., Nilsson, P. M., Pagkalos, E. M., Penfornis, A., et al. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12252 · Cited by 69
Kompaniyets, L., Freedman, D. S., Belay, B., Pierce, S. L., Kraus, E. M., Blanck, H. M., & Goodman, A. B. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.27358 · Cited by 55
DiMattia, Z. S., Damani, J. J., Syoc, E. P. V., & Rogers, C. J. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.100162 · Cited by 72
Koot, D., Goh, P. S. C., Lim, R. S. M., Tian, Y., Yau, T. Y., Tan, N. C., & Finkelstein, E. A. (2019) · JMIR mHealth and uHealth · doi:10.2196/12965 · Cited by 55
Raimundo, A., Félix, F. I. B., Andrade, R., García‐Conesa, M., González‐Sarrías, A., Gilsa-Lopes, J., Ó, D. D., Raimundo, A., Ribeiro, R. T., Rodriguez‐Mateos, A., et al. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02189-1 · Cited by 62
Why are anti-obesity drugs stigmatized?
Halpern, B., & Halpern, A. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.995088 · Cited by 61
Biondi, G., Marrano, N., Borrelli, A., Rella, M., Palma, G., CALDERONI, I., Siciliano, E., Lops, P., Giorgino, F., & Natalicchio, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105522 · Cited by 69
Mancini, M. C., & de Melo, M. E. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0242-0 · Cited by 54
Henning, S. M., Yang, J., Woo, S. L., Lee, R.-P., Huang, J., Rasmusen, A., Carpenter, C. L., Thames, G., Gilbuena, I., Tseng, C.-H., et al. (2019) · Current Developments in Nutrition · doi:10.1093/cdn/nzz068 · Cited by 54
Coupe, N., Peters, S., Rhodes, S., & Cotterill, S. (2019) · BMC Public Health · doi:10.1186/s12889-019-7185-3 · Cited by 65
Shao, S., Chang, K., Lin, S.-J., Chien, R., Hung, M., Chan, Y., Yang, Y. K., & Lai, E. C. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-0990-2 · Cited by 62
New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)
Henry, R. R., Chilton, R., & Garvey, W. T. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.04.011 · Cited by 53
“Specifically, weight loss of 5% to 10% led to a 0.5% reduction in HbA1c, a 5 mm Hg decrease in SBP and diastolic BP (DBP), a 5 mg/dL increase in HDL-cholesterol, and a 40 mg/dL decrease in triglycerides (Wing et al., 2011).”
BackgroundInfluentialPharmacological Approaches in the Treatment and Maintenance of Weight Loss
Van Gaal, L., & Dirinck, E. (2016) · Diabetes Care · doi:10.2337/dcs15-3016 · Cited by 52
Boukabous, I., Marcotte-Chénard, A., Amamou, T., Boulay, P., Brochu, M., Tessier, D., Dionne, I., & Riesco, E. (2019) · Journal of Aging and Physical Activity · doi:10.1123/japa.2018-0309 · Cited by 53
Leibel, R. L., Seeley, R. J., Darsow, T., Berg, E. G., Smith, S. R., & Ratner, R. (2015) · Diabetes · doi:10.2337/db15-0004 · Cited by 52
Małecki, M. T., Batterham, R. L., Sattar, N., Levine, J. A., Rodríguez, Á., Bergman, B. K., Wang, H., Ghimpeteanu, G., & Lee, C. J. (2023) · Diabetes Care · doi:10.2337/dc23-1135 · Cited by 52
Current Approaches to the Management of Pediatric Overweight and Obesity
Coppock, J. H., Ridolfi, D. R., Hayes, J. F., Paul, M. S., & Wilfley, D. E. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0343-0 · Cited by 64
Stockton, A. V. E., Farhat, G., McDougall, G. J., & Al‐Dujaili, E. A. S. (2017) · Journal of Nutritional Science · doi:10.1017/jns.2017.36 · Cited by 52
Sarin, H. V., Lee, J. H., Jauhiainen, M., Joensuu, A., Borodulin, K., Männistö, S., Jin, Z., Terwilliger, J. D., Isola, V., Ahtiainen, J. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40107-6 · Cited by 68
Nutrition knowledge, attitudes, and self-regulation as predictors of overweight and obesity
Balani, R., Herrington, H., Bryant, E., Lucas, C., & Kim, S. C. (2019) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000169 · Cited by 67
Jahangiri-Noudeh, Y., Akbarpour, S., Lotfaliany, M., Zafari, N., Khalili, D., Tohidi, M., Mansournia, M. A., Azizi, F., & Hadaegh, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112639 · Cited by 52
Getting to Equity in Obesity Prevention: A New Framework
Kumanyika, S. (2017) · NAM Perspectives · doi:10.31478/201701c · Cited by 71
López-Domènech, S., Abad-Jiménez, Z., Iannantuoni, F., de Marañón, A. M., Rovira-Llopis, S., Morillas, C., Bañuls, C., Víctor, V. M., & Rocha, M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2018.10.005 · Cited by 51
Primary prevention of cardiovascular disease: Updated review of contemporary guidance and literature
Stewart, J., Addy, K., Campbell, S., & Wilkinson, P. (2020) · JRSM Cardiovascular Disease · doi:10.1177/2048004020949326 · Cited by 82
Squire, P., Naude, J., Zentner, A., Bittman, J., & Khan, N. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-089477 · Cited by 47
Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial
for the POWER-UP Research Group, Vetter, M. L., Wadden, T. A., Chittams, J., Diewald, L. K., Panigrahi, E., Volger, S., Sarwer, D. B., & Moore, R. H. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.92 · Cited by 50
Self-citationDefending the Con Side: Obesity Paradox Does Not Exist
Standl, E., Erbach, M., & Schnell, O. (2013) · Diabetes Care · doi:10.2337/dcs13-2040 · Cited by 50
Darwiche, G., Höglund, P., Roth, B., Larsson, E., Sjöberg, T., Wohlfart, B., Steen, S., & Ohlsson, B. (2016) · Food & Nutrition Research · doi:10.3402/fnr.v60.32594 · Cited by 55
Obesity Pharmacotherapy in Patients With Type 2 Diabetes
Kahan, S., & Fujioka, K. (2017) · Diabetes Spectrum · doi:10.2337/ds17-0044 · Cited by 50
Nakajima, S., Fukasawa, K., Gotoh, M., Murakami‐Murofushi, K., & Kunugi, H. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0468-z · Cited by 54
Pratley, R. E., Kang, J., Trautmann, M. E., Hompesch, M., Han, O., Stewart, J., Sorli, C. H., Jacob, S., & Yoon, K. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13824 · Cited by 49
The role of self-monitoring in the maintenance of weight loss success
Laitner, M. H., Minski, S. A., & Perri, M. G. (2016) · Eating Behaviors · doi:10.1016/j.eatbeh.2016.03.005 · Cited by 49
Zapico, A. G., Benito, P. J., González-Gross, M., Peinado, A. B., Morencos, E., Romero, B., Rojo-Tirado, M. A., Cupeiro, R., Szendrei, B., Butragueño, J., et al. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-1100 · Cited by 49
Samuel‐Hodge, C. D., Holder, J. C., Gizlice, Z., Davis, G., Steele, S. P., Keyserling, T. C., Kumanyika, S., Brantley, P. J., & Svetkey, L. P. (2016) · Obesity · doi:10.1002/oby.21700 · Cited by 53
Chee, W. S. S., Gilcharan Singh, H. K., Hamdy, O., Mechanick, J. I., Lee, V. K. M., Barua, A., Mohd Ali, S. Z., & Hussein, Z. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000384 · Cited by 48
Wong, A., Sanchez‐Gonzalez, M. A., Son, W., Kwak, Y., & Park, S. (2018) · Pediatric Exercise Science · doi:10.1123/pes.2017-0198 · Cited by 63
Farran, B., AlWotayan, R., Alkandari, H., Al-Abdulrazzaq, D., Channanath, A., & Thanaraj, T. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00624 · Cited by 49
Lin, P., Wang, Y., Levine, E., Askew, S., Lin, S., Chang, C., Sun, J., Foley, P., Wang, H., Li, X., et al. (2014) · Obesity · doi:10.1002/oby.20686 · Cited by 48
Fukuda-Tsuru, S., Kakimoto, T., Utsumi, H., Kiuchi, S., & Ishii, S. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.030 · Cited by 50
Tamboli, R. A., Breitman, I., Marks‐Shulman, P. A., Jabbour, K., Melvin, W., Williams, B., Clements, R. H., Feurer, I. D., & Abumrad, N. N. (2014) · Obesity · doi:10.1002/oby.20776 · Cited by 48
Hübner, C., Baldofski, S., Crosby, R. D., Müller, A., de Zwaan, M., & Hilbert, A. (2016) · Appetite · doi:10.1016/j.appet.2016.02.017 · Cited by 61
Chung, H., Mamun, A. A., Huang, M., Long, K. Z., Huang, Y., Shin, S., Hwang, S., & Hsu, C. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12514 · Cited by 50
Drapkina, O. M., Karamnova, N. S., Васильевна, К. А., Gornyi, B., Дадаева, В. А., Drozdova, L. Y., Yeganyan, R. A., Олеговна, Е. С., Izmailova, O. V., Lavrenova, Е. A., et al. (2021) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-2952 · Cited by 64
Effect of Obesogenic Medications on Weight‐Loss Outcomes in a Behavioral Weight‐Management Program
Desalermos, A., Russell, B., Leggett, C., Parnell, A., Ober, K., Hagerich, K., Gerlan, C., Ganji, G., Lee, E., Proudfoot, J. A., et al. (2019) · Obesity · doi:10.1002/oby.22444 · Cited by 47
Di Rosa, C., Lattanzi, G., Spiezia, C., Imperia, E., Piccirilli, S., Beato, I., Gaspa, G., Micheli, V., De Joannon, F., Vallecorsa, N., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192013040 · Cited by 47
Naltrexone/bupropion for binge‐eating disorder: A randomized, double‐blind, placebo‐controlled trial
Grilo, C. M., Lydecker, J. A., Jastreboff, A. M., Pittman, B., & McKee, S. A. (2023) · Obesity · doi:10.1002/oby.23898 · Cited by 47
“The ≥ 5% weight loss category is common in obesity [24] and BED [22, 26] trials and is associated with health benefits [36].”
BackgroundJoo, M., Moon, S., Lee, Y. S., & Kim, M. G. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad017 · Cited by 53
Müllertz, A. L. O., Sandsdal, R. M., Jensen, S. B. K., & Torekov, S. S. (2024) · Obesity Reviews · doi:10.1111/obr.13717 · Cited by 46
Sherwood, N. E., Crain, A. L., Martinson, B. C., Anderson, C. P., Hayes, M. G., Anderson, J. D., Senso, M. M., & Jeffery, R. W. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2012.12.014 · Cited by 47
Gray, L. J., Cooper, N., Dunkley, A., Warren, F. C., Ara, R., Abrams, K., Davies, M. J., Khunti, K., & Sutton, A. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00981.x · Cited by 47
Watson, N., Dyer, K., Buckley, J., Brinkworth, G., Coates, A., Parfitt, G., Howe, P., Noakes, M., & Murphy, K. (2016) · Nutrients · doi:10.3390/nu8050289 · Cited by 46
Piernas, C., Aveyard, P. N., & Jebb, S. A. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.141 · Cited by 55
Waring, M. E., Simas, T. A. M., Oleski, J. L., Xiao, R. S., Mulcahy, J. A., May, C. N., & Pagoto, S. (2018) · Journal of Nutrition Education and Behavior · doi:10.1016/j.jneb.2017.09.025 · Cited by 52
Combined Treatment for Obesity and Depression: A Pilot Study
Faulconbridge, L. F., Driscoll, C. F. B., Hopkins, C. M., Bailer Benforado, B., Bishop‐Gilyard, C., Carvajal, R., Berkowitz, R. I., DeRubeis, R., & Wadden, T. A. (2018) · Obesity · doi:10.1002/oby.22209 · Cited by 47
Self-citationAcceptance-based behavioral treatment for weight control: a review and future directions
Forman, E. M., Butryn, M. L., Manasse, S. M., & Bradley, L. E. (2015) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2014.12.020 · Cited by 47
Foster, G. D., Wadden, T. A., LaGrotte, C. A., Vander Veur, S. S., Hesson, L. A., Homko, C. J., Maschak-Carey, B. J., Barbor, N. R., Bailer, B., Diewald, L., et al. (2013) · Nutrition & Diabetes · doi:10.1038/nutd.2013.3 · Cited by 46
Self-citationMolecular and cellular bases of diabetes: Focus on type 2 diabetes mouse model-TallyHo
Tamarai, K., Bhatti, J. S., & Reddy, P. H. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.05.004 · Cited by 45
Effectiveness of dietetic intervention for people with type 2 diabetes: A meta-analysis
Siopis, G., Colagiuri, S., & Allman-Farinelli, M. A. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.009 · Cited by 56
Jayedi, A., Rashidy‐Pour, A., Soltani, S., Zargar, M. S., Emadi, A., & Shab‐Bidar, S. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0610-y · Cited by 49
George, M. M., & Copeland, K. C. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0334-z · Cited by 50
Dagbasi, A., Lett, A. M., Murphy, K., & Frost, G. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006941 · Cited by 44
“PYY (1-36) is released from L-cells and cleaved by dipeptidyl peptidase IV to form PYY (3-36).”
InfluentialVegan dietary pattern for the primary and secondary prevention of cardiovascular diseases
Rees, K., Al-Khudairy, L., Takeda, A., & Stranges, S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013501.pub2 · Cited by 54
La educación en salud como una importante estrategia de promoción y prevención
Sánchez, L. M. M., Hernández-Sarmiento, J. M., Jaramillo, L. I. J., Villegas-Álzate, J. D., Álvarez-Hernández, L. F., Roldán-Tabares, M. D., Mejía, C. R., Calle-Estrada, M. C., & Ospina-Jiménez, M. C. (2020) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.20.2.3487.2020 · Cited by 222
Metadata
- Authors
- Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., & the Look AHEAD Research Group
- Affiliations
- Brown University (US)
- Wake Forest University Health Sciences (US)
- University of Pennsylvania (US)
- University of Alabama at Birmingham (US)
- National Institutes of Health (US)
- University of Colorado Health (US)
- Johns Hopkins University (US)
- Roybal Comprehensive Health Center, Los Angeles, California
- Corresponding author
- Wing, Rena R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-06-17
- Volume
- 34
- Issue
- 7
- Pages
- 1481-1486
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3120182
- OpenAlex
- W2096048424
- Semantic Scholar
- e255352983f0832ba4b41a003633e20e137c2853
- Cited by
- 1,828
- References
- 31
- Citations by year
- 2026: 86 · 2025: 153 · 2024: 136 · 2023: 145 · 2022: 146 · 2021: 143 · 2020: 139 · 2019: 146 · 2018: 126 · 2017: 125 · 2016: 137 · 2015: 99 · 2014: 104 · 2013: 80 · 2012: 49
- FWCI
- 64.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079637, P30DK017047)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- weight loss, type 2 diabetes, cardiovascular risk factors, obesity, overweight, Look AHEAD trial, glycemic control, HbA1c, blood pressure, triglycerides, HDL cholesterol, LDL cholesterol
- MeSH terms
- Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Life Style, Male, Middle Aged, Obesity, Patient Education as Topic, Risk Factors, Weight Loss, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.